Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8506010rdf:typepubmed:Citationlld:pubmed
pubmed-article:8506010lifeskim:mentionsumls-concept:C0026769lld:lifeskim
pubmed-article:8506010lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:8506010lifeskim:mentionsumls-concept:C0007806lld:lifeskim
pubmed-article:8506010lifeskim:mentionsumls-concept:C0015214lld:lifeskim
pubmed-article:8506010lifeskim:mentionsumls-concept:C0348026lld:lifeskim
pubmed-article:8506010lifeskim:mentionsumls-concept:C0028580lld:lifeskim
pubmed-article:8506010lifeskim:mentionsumls-concept:C0040395lld:lifeskim
pubmed-article:8506010lifeskim:mentionsumls-concept:C1522609lld:lifeskim
pubmed-article:8506010lifeskim:mentionsumls-concept:C1554112lld:lifeskim
pubmed-article:8506010pubmed:issue4lld:pubmed
pubmed-article:8506010pubmed:dateCreated1993-7-6lld:pubmed
pubmed-article:8506010pubmed:abstractTextSeventy patients with multiple sclerosis (according to Poser's criteria) were clinically assessed and examined with MRI, multimodal evoked potentials (VEP, AEP, SSEP) and CSF analysis (transformed lymphocytes, IgG-Index, oligoclonal banding). In relation to the clinical criteria of McAlpine 40 patients had possible, 16 patients probable and 14 patients definite MS. 81% of the patients (73% possible MS, 94% probable MS, 93% definite MS) had multiple white matter lesions detected by MRI, 79% (78% possible MS, 94% probable MS, 64% definite MS) had an abnormal CSF profile and 67% (60% possible MS, 75% probable MS, 79% definite MS) abnormal results in multimodal EP testing. Of the patients who experienced only one attack (n = 40) 78% had multiple lesions on MRI, 88% had abnormal CSF-findings and 60% had pathologic EPs. Patients with two or more attacks showed in 87% multiple lesions on MRI, in 77% abnormal EPs and in 70% abnormal CSF findings. The number of abnormal MRI and EPs increases with the duration of the disease. 13 patients with a normal MRI were discussed separately. MRI is the most sensitive method in detecting the spatial pattern of disseminated lesions. To monitor the dissemination over time a careful clinical follow-up is still mandatory.lld:pubmed
pubmed-article:8506010pubmed:languagegerlld:pubmed
pubmed-article:8506010pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8506010pubmed:citationSubsetIMlld:pubmed
pubmed-article:8506010pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8506010pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8506010pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8506010pubmed:statusMEDLINElld:pubmed
pubmed-article:8506010pubmed:monthAprlld:pubmed
pubmed-article:8506010pubmed:issn0028-2804lld:pubmed
pubmed-article:8506010pubmed:authorpubmed-author:LadurnerGGlld:pubmed
pubmed-article:8506010pubmed:authorpubmed-author:StaffenWWlld:pubmed
pubmed-article:8506010pubmed:authorpubmed-author:TrinkaEElld:pubmed
pubmed-article:8506010pubmed:issnTypePrintlld:pubmed
pubmed-article:8506010pubmed:volume64lld:pubmed
pubmed-article:8506010pubmed:ownerNLMlld:pubmed
pubmed-article:8506010pubmed:authorsCompleteYlld:pubmed
pubmed-article:8506010pubmed:pagination226-32lld:pubmed
pubmed-article:8506010pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:meshHeadingpubmed-meshheading:8506010-...lld:pubmed
pubmed-article:8506010pubmed:year1993lld:pubmed
pubmed-article:8506010pubmed:articleTitle[The diagnostic value of nuclear magnetic resonance tomography, multimodal evoked potentials and cerebrospinal fluid examination in multiple sclerosis].lld:pubmed
pubmed-article:8506010pubmed:affiliationNeurologische Abteilung, Landesnervenklinik Salzburg.lld:pubmed
pubmed-article:8506010pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8506010pubmed:publicationTypeEnglish Abstractlld:pubmed